WESTPORT, CT/MEXICO CITY – Megafarma, an Azelis company, has been authorized by BASF Monomers, a leader in the development, production and sale of polyurethanes, to distribute its polyurethane raw materials in Mexico. The exclusive distribution agreement includes BASF’s lines of Lupranate® isocyanates and Pluracol® polyols. The agreement is effective immediately.

This agreement further strengthens Azelis’ strategic acquisition of Megafarma earlier this year to expand into the Latin American CASE market. It leverages existing Azelis Americas CASE assets, including application labs, digital platforms, and technical and market intelligence, in the Mexican market. The agreement is in line with Azelis’ corporate strategy of organic growth through the expansion of existing relationships with key principals into new territories.

Martin Hernandez Gutiérrez, Director General at Megafarma, said, “Megafarma has been very successful in life sciences in Mexico, and the merger with Azelis earlier this year brought us new opportunities and enabled us to enter new market segments. This new agreement with BASF is the latest example of our commitment to expand into Mexican CASE sector and become a leading distributor with unsurpassed quality, logistics and technical support for our customers and principals.”

Dan Gruber, Managing Director, New Business Development, Azelis Americas CASE, said, “We have a longstanding relationship with BASF. In the U.S and Canada we have demonstrated organic growth via our dedicated and technically trained sales force, and our application labs have been instrumental in our joint success. We are very excited about this expansion into the Mexican market as it allows us to deliver the same value and growth that we have provided BASF Polyurethanes in the U.S and Canada.”

Rachel Miller, CASE Distribution, Monomers, North America, BASF Corporation, said, “This collaboration with Megafarma will provide our CASE specialties customers in Mexico with the service and expertise our U.S. customers are accustomed to. Our portfolio of Lupranate isocyanates and Pluracol polyols can be formulated to create a variety of specialty products now in Mexico.”